{"Beilstein Registry Numbers": ["4263164"], "CAS Registry Numbers": ["100643-71-8"], "ChEBI ID": 291342, "ChEBI Name": "desloratadine", "Charge": 0, "Definition": "Loratadine in which the ethoxycarbonyl group attached to the piperidine ring is replaced by hydrogen. The major metabolite of loratidine, desloratadine is an  antihistamine which is used for the symptomatic relief of allergic conditions including rhinitis and chronic urticaria. It does not readily enter the central nervous system, so does not cause drowsiness.", "DrugBank Database Links": ["DB00967"], "Formulae": ["C19H19ClN2"], "INN": ["desloratadine"], "IUPAC Names": ["8-chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine"], "InChI": ["InChI=1S/C19H19ClN2/c20-16-5-6-17-15(12-16)4-3-14-2-1-9-22-19(14)18(17)13-7-10-21-11-8-13/h1-2,5-6,9,12,21H,3-4,7-8,10-11H2"], "InChIKey": ["JAUOIFJMECXRGI-UHFFFAOYSA-N"], "KEGG DRUG Database Links": ["D03693"], "LINCS Database Links": ["LSM-5887"], "Mass": 310.821, "Molfile": "\n  Marvin  07091011422D          \n\n 22 25  0  0  0  0            999 V2000\n    8.8115   -6.0335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.5569   -5.6812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    8.0667   -5.6790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.7349   -4.8817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    8.8136   -6.8738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   10.1709   -6.2474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.4438   -6.2337    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    7.8821   -4.8794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   10.5338   -4.6314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    8.8163   -8.5412    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    9.2050   -4.2598    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    8.4096   -4.2598    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   11.1405   -5.1904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   10.9591   -5.9981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   11.9320   -4.9424    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0\n    8.1080   -7.3040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.5212   -7.3006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.5314   -8.1249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    8.0995   -8.1279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.6559   -6.0047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.0810   -4.6397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.4710   -5.1935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n  2  1  1  0  0  0  0\n  3  1  1  0  0  0  0\n  4  2  2  0  0  0  0\n  5  1  2  0  0  0  0\n  6  2  1  0  0  0  0\n  7  3  2  0  0  0  0\n  8  3  1  0  0  0  0\n  9  4  1  0  0  0  0\n 10 18  1  0  0  0  0\n 11  4  1  0  0  0  0\n 12  8  1  0  0  0  0\n 13 14  1  0  0  0  0\n 14  6  2  0  0  0  0\n 15 13  1  0  0  0  0\n 16  5  1  0  0  0  0\n 17  5  1  0  0  0  0\n 18 17  1  0  0  0  0\n 19 16  1  0  0  0  0\n 20  7  1  0  0  0  0\n 21  8  2  0  0  0  0\n 22 21  1  0  0  0  0\n 10 19  1  0  0  0  0\n 12 11  1  0  0  0  0\n 20 22  2  0  0  0  0\n  9 13  2  0  0  0  0\nM  END", "Monoisotopic Mass": 310.12368, "Patent Database Links": ["EP208855", "US4659716"], "PubChem Database Links": ["CID: 124087", "SID: 85483828"], "PubMed Citation Links": ["11844681", "15482930", "9934454"], "SMILES": ["Clc1ccc2c(CCc3cccnc3C2=C2CCNCC2)c1"], "Star": 3, "Synonyms": ["8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine", "8-chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine", "DESLORATADINE", "descarboethoxyloratadine"], "Wikipedia Database Links": ["Desloratadine"]}
{"Beilstein Registry Numbers": ["9608167"], "CAS Registry Numbers": ["188627-80-7"], "ChEBI ID": 291902, "ChEBI Name": "eptifibatide", "Charge": 0, "Definition": "A synthetic homodetic cyclic peptide comprising <element>N</element><smallsup><locant>alpha</locant></smallsup>-(3-sulfanylpropanoyl)homoarginyl, glycyl, aspartyl, tryptophyl, prolyl and cysteinamide residues connected in sequence and cyclised via a disulfide bond. Derived from a protein found in the venom of the southeastern pygmy rattlesnake, <ital>Sistrurus miliarus barbouri</ital>, eptifibatide is an anti-coagulant that inhibits platelet aggregation by selectively blocking the platelet glycoprotein IIb/IIIa receptor, so preventing the binding of fibrinogen, von Willebrand factor, and other adhesive ligands. It is used in the management of unstable angina and in patients undergoing coronary angioplasty and stenting procedures.", "DrugBank Database Links": ["DB00063"], "Formulae": ["C35H49N11O9S2"], "IUPAC Names": ["[(3R,11S,17S,20S,25aS)-11-(4-carbamimidamidobutyl)-3-carbamoyl-20-(1H-indol-3-ylmethyl)-1,9,12,15,18,21-hexaoxodocosahydro-7H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosin-17-yl]acetic acid"], "InChI": ["InChI=1S/C35H49N11O9S2/c36-30(51)25-18-57-56-13-10-27(47)42-22(8-3-4-11-39-35(37)38)31(52)41-17-28(48)43-23(15-29(49)50)32(53)44-24(14-19-16-40-21-7-2-1-6-20(19)21)34(55)46-12-5-9-26(46)33(54)45-25/h1-2,6-7,16,22-26,40H,3-5,8-15,17-18H2,(H2,36,51)(H,41,52)(H,42,47)(H,43,48)(H,44,53)(H,45,54)(H,49,50)(H4,37,38,39)/t22-,23-,24-,25-,26-/m0/s1"], "InChIKey": ["CZKPOZZJODAYPZ-LROMGURASA-N"], "KEGG DRUG Database Links": ["D06888"], "Mass": 831.962, "Molfile": "\n  Marvin  07291016512D          \n\n 58 61  0  0  1  0            999 V2000\n   17.9417   -7.0890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   18.6561   -7.5016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   18.6561   -8.3266    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   15.7983   -8.3266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   15.7983   -9.9766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   15.7983  -10.8015    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n   16.5128  -11.2140    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   18.6558   -9.9765    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   17.9415  -11.2138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   18.6558  -10.8014    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n   19.3706   -8.7390    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n   19.3706   -9.5639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   15.7983   -7.5016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   16.5128   -7.0890    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   16.5128   -6.2640    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n   17.2273   -5.8515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   17.9417   -6.2640    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   16.5129  -12.0388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   17.2273  -12.4512    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n   17.9416  -12.0387    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   15.0634   -8.5077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   15.0634   -9.7955    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0\n   14.7054   -9.1516    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0\n   17.3989  -13.2580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   18.2192  -13.3441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   18.5547  -12.5906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   15.7985  -12.4514    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   17.2270  -10.8014    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   20.0851   -9.9764    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   19.3706   -7.0890    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   17.2273   -5.0265    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   15.0838   -7.0890    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   19.4619  -10.9733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   19.7170  -11.7579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   19.2316  -12.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   19.7161  -13.0928    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   20.5014  -12.0134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   20.5010  -12.8384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   20.0850   -8.3264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   20.7996   -8.7389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   21.5140   -8.3264    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   20.7996   -9.5639    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   15.7983   -5.8515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   15.0839   -6.2640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   14.3694   -5.8515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   13.6549   -6.2640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   13.6549   -7.0890    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   12.9404   -7.5015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   12.9404   -8.3265    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   12.2259   -7.0889    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   15.0839  -11.2141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   14.3694  -10.8016    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   15.0839  -12.0391    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   21.9304  -12.0134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   21.9304  -12.8384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   21.2159  -11.6009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   21.2159  -13.2509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   18.8658  -11.5998    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0\n  2  1  1  0  0  0  0\n  3  2  1  0  0  0  0\n  6  5  1  0  0  0  0\n  7  6  1  0  0  0  0\n 10  8  1  0  0  0  0\n  9 10  1  0  0  0  0\n 11  3  1  0  0  0  0\n 12  8  1  0  0  0  0\n 12 11  1  0  0  0  0\n  4 13  1  0  0  0  0\n 14 13  1  0  0  0  0\n 14 15  1  0  0  0  0\n 16 15  1  0  0  0  0\n 17 16  1  0  0  0  0\n  1 17  1  0  0  0  0\n 18  7  1  0  0  0  0\n 19 18  1  1  0  0  0\n 20  9  1  0  0  0  0\n 21  4  1  0  0  0  0\n 23 21  1  0  0  0  0\n 22  5  1  0  0  0  0\n 23 22  1  0  0  0  0\n 24 19  1  0  0  0  0\n 20 19  1  0  0  0  0\n 25 24  1  0  0  0  0\n 26 20  1  0  0  0  0\n 26 25  1  0  0  0  0\n 18 27  2  0  0  0  0\n  9 28  2  0  0  0  0\n 12 29  2  0  0  0  0\n  2 30  2  0  0  0  0\n 16 31  2  0  0  0  0\n 13 32  2  0  0  0  0\n 10 33  1  1  0  0  0\n 33 34  1  0  0  0  0\n 34 35  2  0  0  0  0\n 36 35  1  0  0  0  0\n 37 34  1  0  0  0  0\n 38 36  1  0  0  0  0\n 11 39  1  1  0  0  0\n 39 40  1  0  0  0  0\n 40 41  1  0  0  0  0\n 40 42  2  0  0  0  0\n 15 43  1  1  0  0  0\n 43 44  1  0  0  0  0\n 44 45  1  0  0  0  0\n 45 46  1  0  0  0  0\n 46 47  1  0  0  0  0\n 47 48  1  0  0  0  0\n 48 49  2  0  0  0  0\n 48 50  1  0  0  0  0\n  6 51  1  6  0  0  0\n 51 52  1  0  0  0  0\n 51 53  2  0  0  0  0\n 55 54  1  0  0  0  0\n 56 54  2  0  0  0  0\n 57 55  2  0  0  0  0\n 37 56  1  0  0  0  0\n 38 57  1  0  0  0  0\n 38 37  2  0  0  0  0\n 10 58  1  6  0  0  0\nM  END", "Monoisotopic Mass": 831.31561, "Patent Database Links": ["US5686570"], "PubChem Database Links": ["CID: 448812", "SID: 85484373"], "SMILES": ["[H][C@@]1(Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)CCSSC[C@H](NC(=O)[C@@H]2CCCN2C1=O)C(N)=O"], "Star": 3, "Synonyms": ["EPTIFIBATIDE", "N(6)-amidino-N(2)-(3-mercaptopropionyl)-L-lysylglycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide, cyclic(1-6)-disulfide", "S(1),S(6)-cyclo[N(6)-carbamimidoyl-N(2)-(3-sulfanylpropanoyl)-L-lysylglycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide]"], "UniProt Database Links": ["P22827"], "Wikipedia Database Links": ["Eptifibatide"]}
